Characterization of Immunoactive and Immunotolerant CD4+ T Cells in Breast Cancer by Measuring Activity of Signaling Pathways That Determine Immune Cell Function

SIMPLE SUMMARY: Immunotherapy enhances the immune response against cancer and is potentially curative. Unfortunately, few patients with breast cancer benefit from this therapy. It is not possible to predict which patients will benefit. A blood cell, called CD4+ T-cell, plays a role in the immune res...

Descripción completa

Detalles Bibliográficos
Autores principales: Wesseling-Rozendaal, Yvonne, van Doorn, Arie, Willard-Gallo, Karen, van de Stolpe, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833374/
https://www.ncbi.nlm.nih.gov/pubmed/35158758
http://dx.doi.org/10.3390/cancers14030490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833374/
https://www.ncbi.nlm.nih.gov/pubmed/35158758
http://dx.doi.org/10.3390/cancers14030490

Ejemplares similares